Dr. Joshua Brody, MD @joshuabrodyMD Director, Lymphoma Immunotherapy Program Icahn School of Medicine at Mount Sinai talks about Combining Antibody TherapyWith BTK Inhibitor in Folicular Lymphoma at ASH 2015
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content